News
Bitcoin Breakthrough: SEC approves Bitcoin ETFs
The U.S. Securities and Exchange Commission (SEC) has given the go-ahead to the first-ever U.S.-listed exchange-traded funds (ETFs) tracking Bitcoin. This watershed moment marks a significant leap
Is EchoStar a buy after the Dish Network buyout?
Satellite network operator EchoStar Co. (NASDAQ: SATS) completed its merger with broadband and pay-tv services provider DISH Network Co. (NASDAQ: DISH) on December 31, 2023. Together, they formed
Peloton Stock surges on TikTok deal...can it keep up the pace?
In an attempt to revive its stagnant subscriber base, Peloton Interactive, Inc. (NASDAQ:PTON) is turning to TikTok.
Last week, the connected fitness company announced its own connection with the
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
Hospital chain HCA Healthcare, Inc. (NYSE: HCA) has been working on a bullish base and even managed to post gains in a week when the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) pulled back.
Investors
Rare chart pattern setting up 3 stocks for upside trade
Axon Enterprise Inc. (NASDAQ: AXON), MercadoLibre Inc. (NASDAQ: MELI) and e.l.f. Beauty Inc. (NYSE: ELF) all traded lower along with the broader market in the first week of the year, but a
3 reasons 2024 Moderna shareholders may party like it's 2021
In a letter released to shareholders this week, Moderna Inc. (NASDAQ:MRNA) CEO Stephane Bancel stated, “Our mRNA platform is working.” Referring to the company’s groundbreaking messenger RNA drug
Hidden gems: 3 undervalued stocks with a unique competitive edge
Companies with unique competitive advantages aren’t always rewarded by the market: Etsy Inc. (NASADQ: ETSY), International Flavors & Fragrances Inc. (NYSE: IFF) and Zimmer Biomet Holdings Inc.
Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals
Bristol Myers Squibb Company (NYSE: BMY) is on a buying spree, announcing two acquisitions in less than a week.
On December 22, the pharma giant said it was acquiring Karuna Therapeutics Inc.
5 Biotech stocks tapping into unmet mental health treatment needs
Anyone who has dealt with a mental illness or has a loved one who struggles with a mental illness knows how devastating these diseases are. However, a growing number of biotechnology companies are
Wingstop due for a correction, but don’t fly the coop
There are many reasons to fear a correction in Wingstop Inc. (NASDAQ: WING), but investors shouldn't get ready to fly the coop. While a correction is more than due, the trajectory for growth
2 former tech trailblazers rising like a phoenix
The computer and technology sector is constantly evolving as companies rise and fall with each new trend and innovation. It's common to see former leaders and high flyers flame out as new leaders
2 retail stocks to watch as potential takeover targets in 2024
The investor-led $5.8 billion bid for the acquisition of Macy's Inc. (NYSE: M) sent the company's shares soaring over 20%. Retailer stocks in the consumer discretionary sector spiked as well
UiPath stock: Breaking Out Amidst Shifting Sentiment
The year is coming to a close in quite some fashion, with the technology sector fresh off of hitting new all-time highs. For the entire year, the technology sector has firmly led the way, with
3 stocks getting upgraded ahead of 2024
As weeks go, it's been a great one for equities. The S&P 500 index has hit its highest levels in almost two years and has gained 14% since the end of October. Much of this is due to the Fed
Alaska Air Stock : Time to say 'aloha' after Hawaiian buyout dip?
Like many winter-weary travelers, Alaska Air Group, Inc. (NYSE:ALK) is getting into a tropical mood this time of year.
This month, the Seattle-based airliner announced a plan to acquire
Jetblue raises guidance: Can the airlines take flight in 2024?
Jetblue (NASDAQ: JBLU) raised guidance for Q4 and the year, suggesting it will carry momentum into 2024. The news helped lift the stock and the airline complex with it, raising the question, can
3 tax-loss selling buys to start 2024 with double-digit gains
The end of the year brings with it portfolio adjustments, window dressing and tax harvesting. This results in fund managers and investors selling their losers and buying the winners. The wash rule
The most upgraded retail stocks that should be on your radar
Retailers have certainly had a tough time in 2023, but not all experience the same headwinds. While names like Target struggle to gain traction, others outperform their estimates and grow. Even in
Transportation industry breakout will make these stocks rally
There's a blueprint behind every winning investment that tends to be forgotten during the good and easy times in the stock market. However, following a solid plan is being called for in today's
Is the Automotive Industry's Transition to 100% Battery Electric Vehicles (EVs) the Most Effective Way to Decarbonize European Transport?
Garrett Motion White Paper Tackles Key Question Regarding Vehicle CO2 Emissions
- Vehicle lifecycle study (LCA) evaluates the years of use required for battery electric vehicles
The rally in Braze, Inc. gains momentum: 30% upside potential
Braze, Inc. (NASDAQ: BRZE) emerged as a solid play on business services, AI and cloud stocks earlier this year, and it is gaining momentum. The Q3 results were strong enough to spark a series of
3 S&P 500 stocks with rising short interest
Thanks to a stellar November, the S&P 500 is within 250 points of its all-time high from almost two years ago. But to some investors, this is reason to be bearish.
Since the fall season began
Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event
The Company's ESG strategy demonstrates its efforts to advance global health and environmental sustainability, as well as its commitments to employees and communities
CAMBRIDGE, MA /
Moderna präsentiert auf der zweiten ESG-Investorenveranstaltung seine Fortschritte und Ziele im Bereich Umwelt, Soziales und Governance (ESG)
Die ESG-Strategie des Unternehmens veranschaulicht seine Anstrengungen, im Bereich der weltweiten Gesundheit und der ökologischen Nachhaltigkeit sowie seiner Verpflichtungen gegenüber
Nutanix nails 52-week highs on AI-driven growth
Nutanix Inc. (NASDAQ: NTNX) shares soared to a new 52-week high driven by a strong fiscal Q1 2024 earnings beat and raised guidance. The Company provides hyperconverged IT infrastructure services